LongBio Pharma (Suzhou) Co., Ltd. announced the latest composition of its Board of Directors and detailed committee roles, effective 4 June 2026.

The 11-member Board is led by Executive Director Dr. Liu Heng, who also serves as Chairperson of the Nomination Committee. Executive Directors include Dr. Sun Bill Nai-chau and Mr. Xie Ming.

Non-executive Directors comprise Mr. Lin Jian, Ms. Gu Qin, Dr. Xue Di and Dr. Chen Kan.

Independent Non-executive Directors (INEDs) are Mr. Siu Paul Yu Hay, Mr. Ruan Tim, Mr. Yang Chun and Mr. Zhou Guofang, providing external oversight across the Board and its committees.

Committee leadership and membership are as follows: • Audit Committee: Chaired by INED Mr. Siu Paul Yu Hay; members include Mr. Xie Ming and Mr. Lin Jian. • Remuneration Committee: Chaired by INED Mr. Yang Chun; members are Ms. Gu Qin and Mr. Ruan Tim. • Nomination Committee: Chaired by Dr. Liu Heng; members include Mr. Siu Paul Yu Hay, Mr. Ruan Tim, Mr. Yang Chun and Mr. Zhou Guofang.

The announcement underscores LongBio Pharma’s commitment to balanced governance, combining executive insight with independent oversight through its committee structure.